Concepedia

Brunda Ganneru

BG

Statistics

Publications

15

Citations

1.4K

H-Index

13

Active since

2010

Affiliations

Bharat Biotech (India)(Current)

ICMR-National Institute of Virology

All India Institute of Medical Sciences

Indian Council of Medical Research

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences

Brunda Ganneru is an author at Bharat Biotech (India) specializing in vaccine development, medicine, and vaccination.

Top concepts

Publications per year

2010–2023

15

Publications

15

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 433 citations · Full text

, , +6

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 360 citations · Full text

Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation

Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram et al. · iScience · 2021 · 92 citations · Full text

The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit

Rashmi Jalah, Margherita Rosati, Brunda Ganneru et al. · Journal of Biological Chemistry · 2013 · 78 citations · Full text

Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

Chandramani Singh, Savita Verma, Prabhakar Reddy et al. · npj Vaccines · 2023 · 74 citations · Full text

1–5 of 15